ロード中...
Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group
The efficacy and safety of lamotrigine extended-release tablets (LTG XR) as monotherapy for partial seizures were evaluated using the conversion-to-monotherapy design, and historical data as the control. This methodology was recently approved by the United States Food and Drug Administration, and th...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3271149/ https://ncbi.nlm.nih.gov/pubmed/22139591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-011-0088-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|